Check out the companies that are making the headlines before the bell:
JUICE The German enterprise software company has risen after it was announced that the Qualtrics division has filed for an IPO. Qualtrics – specializing in customer relationship software – is expected to be valued at $ 12 billion or more, compared to the $ 8 billion SAP paid to acquire Qualtrics two years ago. The shares were slightly higher at 7:45 a.m.CET.
Boeing – Boeing is on guard today American Airlines is the first US airline to offer the updated 737 Max-Jet with a Flight from Miami to New York’s LaGuardia Airport. The jet was grounded in early 2019 after two fatal crashes. The Boeing share gained 1.5% at around 7:45 a.m.CET.
Cisco Systems – According to a Cisco spokesperson, Cisco is pulling the plug from its “Smart Cities” project known as “Cisco Kinetic for Cities” quoted by the Wall Street Journal. The project was part of an effort to expand Cisco beyond its traditional network equipment and hardware to the more lucrative software services business.
target Target sold its Dermstore operation to UK-based online retailer THG Holdings for $ 350 million in cash. Dermstore is an online skin care and beauty product retailer. The target stocks were slightly higher at 7.45 a.m. CET.
Barnes and Noble Education The college campus bookstore chain plans to continue recent cost-cutting efforts, said CFO Thomas Donohue in one Interview with the Wall Street Journal. The cost reductions are in anticipation of another semester of distance learning. The company’s stock rose nearly 13% at 7:45 a.m. ET.
Alibaba – The China-based e-commerce company remains vigilant after bouncing off its 13.3% decline last Thursday with a very slight gain on Monday. The decrease was due to the increased antitrust control by the Chinese regulatory authorities. Alibaba stock gained 3% as of 7.45 a.m. ET.
lemonade – Approximately 44 million shares of the online insurance company will be listed for sale today as the insider sales embargo expires. As expected, the stock has fallen sharply in the last two trading days, losing about 7% last Thursday and another 14% yesterday. As of 7.45 a.m. CET, the share had lost another 4.5%
Alkermes The Dublin-based biopharmaceutical company announced that the FDA has accepted the re-submission of its treatment known as ALKS 3831 for schizophrenia and certain types of bipolar disorder in adults. The company said that following an FDA review of an Alkermes manufacturing facility in Ohio, no issues were found and the company does not need to conduct new trials. The company’s stock rose 3% at 7:45 a.m. ET.
Bausch health The drug company said it plans to use cash and operating money to pay off an additional $ 275 million in debt.
Arcturus Therapeutics – The San Diego-based biotech company’s shares fell more than 35% in premarket trading after data was released on its vaccine candidate Covid-19. That comes despite the favorable study results mentioned by Arcturus. The company announced that Phase 3 trials will take place in the second quarter of 2021.
Fiat Chrysler – The automaker plans to invest around $ 2.5 billion in its Tychy, Poland plant, according to Polish deputy Prime Minister Jaroslaw Gowin. The facility is being modernized to produce hybrid and electric versions of the Jeep, Fiat and Alfa Romeo models. Fiat Chrysler’s stock was up a fraction of 1% at 7:45 a.m. ET.
Source link
This article originally appeared on www.cnbc.com
